Recurrent Glioblastoma Stocks List
Related Industries: Biotechnology
Related Stock Lists:
Advanced Breast Cancer
Antibody Drug Conjugate
Biopharmaceutical
Biotechnology
Blastoma
Brain Tumor
Breast Cancer
Cancer
Cancer Center
Cancer Research
Cancer Treatment
Clinical Development
Clinical Medicine
Complement System
Dendritic Cell
Genetics
Glioblastoma
Hematologic Cancers
Immune System
Immunology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PBE | C | PowerShares Dynamic Biotech & Genome | 2.79 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 1.63 | |
XBI | D | SPDR S&P Biotech ETF | 0.87 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.86 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 0.55 |
Compare ETFs
Date | Stock | Title |
---|---|---|
May 15 | CLDX | Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis |
Related Industries:
Biotechnology
Related Stock Lists:
Advanced Breast Cancer
Antibody Drug Conjugate
Biopharmaceutical
Biotechnology
Blastoma
Brain Tumor
Breast Cancer
Cancer
Cancer Center
Cancer Research
Cancer Treatment
Clinical Development
Clinical Medicine
Complement System
Dendritic Cell
Genetics
Glioblastoma
Hematologic Cancers
Immune System
Immunology
- Recurrent Glioblastoma
Recurrent glioblastoma is a type of brain cancer that has returned after initial treatment. It is an aggressive form of cancer that is difficult to treat. It is characterized by the growth of abnormal cells in the brain that form tumors. Symptoms of recurrent glioblastoma can include headaches, seizures, changes in vision, and difficulty with speech and movement. Treatment options may include surgery, radiation, chemotherapy, and targeted therapy.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles